According to Telix Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.33. In 2022 the company made an earnings per share (EPS) of -$0.33 a decrease over its 2021 EPS that were of -$0.30.
Year | EPS | Change |
---|---|---|
2022 | -$0.33 | 10.63% |
2021 | -$0.30 | 53.99% |
2020 | -$0.19 | 60.51% |
2019 | -$0.12 | 73.49% |
2018 | -$0.06928 | 24.02% |
2017 | -$0.05586 | |
2000 | -$0.01211 | 72% |
1999 | -$0.007041 |